Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors by Monia Sisi, MD, Giovanni Vitale, MD, PhD, Michele Fusaroli, MD, Mattia Riefolo, MD, Valentina Giunchi, BSc, Antonietta D’Errico, MD, Andrea Ardizzoni, MD, Emanuel Raschi, MD, PhD, Francesco Gelsomino, MD

Get full text